Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Mastronuzzi

Showing results (171-180 of 259) with videos related to

Pageof 26
Sort By:
American Journal of Medical Genetics. Part A|June 11, 2022
Posterior fossa ependymoma in neurodevelopmental syndrome caused by a de novo germline pathogenic POLR2A variantRoberto Paparella, Anna Maria Caroleo, Emanuele Agolini, et al.
Scientific Reports|February 25, 2018
Foxm1 controls a pro-stemness microRNA network in neural stem cellsZein Mersini Besharat, Luana Abballe, Francesco Cicconardi, et al.
Frontiers in Oncology|November 16, 2020
Cancer Predisposition Syndromes and Medulloblastoma in the Molecular EraRoberto Carta, Giada Del Baldo, Evelina Miele, et al.
Health and Quality of Life Outcomes|July 12, 2023
The Italian version of the Pediatric Quality of Life Inventory™ (PEDSQL™) 3.0 healthcare satisfaction hematology/oncology module: reliability and validity in radiation oncologyElisa Marconi, Francesco Beghella Bartoli, Elisa Meldolesi, et al.
JNCI Cancer Spectrum|January 28, 2025
Cancer risk in carriers of TP53 germline variants grouped into different functional categoriesLucas John Müntnich, Christina M Dutzmann, Anika Großhennig, et al.
Journal of Neuro-Oncology|October 29, 2025
Clinical, toxicity and long-term neurocognitive outcomes of first-line intensive chemotherapy in infant medulloblastoma: a single-center cohort study following AIEOP recommendationsGiada Del Baldo, Valentina Di Ruscio, Antonella Cacchione, et al.
Frontiers in Oncology|October 20, 2023
Unraveling the impact of upfront chemotherapy and proton beam therapy on treatment outcome and follow-up in central nervous system germ cell tumors: a single center experienceGiada Del Baldo, Sabina Vennarini, Maristella Toniutti, et al.
Cancers|March 25, 2022
Short and Long-Term Toxicity in Pediatric Cancer Treatment: Central Nervous System DamageIside Alessi, Anna Maria Caroleo, Luca de Palma, et al.
Scientific Reports|September 13, 2024
The coexistence of a BRCA2 germline and a DICER1 somatic variant in two first-degree cousins suggests their potential synergic effectGiada Del Baldo, Angela Mastronuzzi, Selene Cipri, et al.
Frontiers in Molecular Neuroscience|September 11, 2023
SHH medulloblastoma and very early onset of bowel polyps in a child with <i>PTEN</i> hamartoma tumor syndromeAnna Maria Caroleo, Silvia Rotulo, Emanuele Agolini, et al.
Pageof 26

Showing results (171-180 of 259) with videos related to

Sort By:
Pageof 26
American Journal of Medical Genetics. Part A|June 11, 2022
Posterior fossa ependymoma in neurodevelopmental syndrome caused by a de novo germline pathogenic POLR2A variantRoberto Paparella, Anna Maria Caroleo, Emanuele Agolini, et al.
Scientific Reports|February 25, 2018
Foxm1 controls a pro-stemness microRNA network in neural stem cellsZein Mersini Besharat, Luana Abballe, Francesco Cicconardi, et al.
Frontiers in Oncology|November 16, 2020
Cancer Predisposition Syndromes and Medulloblastoma in the Molecular EraRoberto Carta, Giada Del Baldo, Evelina Miele, et al.
Health and Quality of Life Outcomes|July 12, 2023
The Italian version of the Pediatric Quality of Life Inventory™ (PEDSQL™) 3.0 healthcare satisfaction hematology/oncology module: reliability and validity in radiation oncologyElisa Marconi, Francesco Beghella Bartoli, Elisa Meldolesi, et al.
JNCI Cancer Spectrum|January 28, 2025
Cancer risk in carriers of TP53 germline variants grouped into different functional categoriesLucas John Müntnich, Christina M Dutzmann, Anika Großhennig, et al.
Journal of Neuro-Oncology|October 29, 2025
Clinical, toxicity and long-term neurocognitive outcomes of first-line intensive chemotherapy in infant medulloblastoma: a single-center cohort study following AIEOP recommendationsGiada Del Baldo, Valentina Di Ruscio, Antonella Cacchione, et al.
Frontiers in Oncology|October 20, 2023
Unraveling the impact of upfront chemotherapy and proton beam therapy on treatment outcome and follow-up in central nervous system germ cell tumors: a single center experienceGiada Del Baldo, Sabina Vennarini, Maristella Toniutti, et al.
Cancers|March 25, 2022
Short and Long-Term Toxicity in Pediatric Cancer Treatment: Central Nervous System DamageIside Alessi, Anna Maria Caroleo, Luca de Palma, et al.
Scientific Reports|September 13, 2024
The coexistence of a BRCA2 germline and a DICER1 somatic variant in two first-degree cousins suggests their potential synergic effectGiada Del Baldo, Angela Mastronuzzi, Selene Cipri, et al.
Frontiers in Molecular Neuroscience|September 11, 2023
SHH medulloblastoma and very early onset of bowel polyps in a child with <i>PTEN</i> hamartoma tumor syndromeAnna Maria Caroleo, Silvia Rotulo, Emanuele Agolini, et al.
Pageof 26